← Eichor
Condition: Urge Urinary Incontinence Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Urge Urinary Incontinence

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Wome
Phase 4 · 14 location(s) · Mansoura University · NCT07416968Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial
NA · 1 location(s) · Benha University · NCT07184307Percutaneous Nerve Evaluation Trial Time
NA · 1 location(s) · University of Chicago · NCT06226220Safety and Performance of UCon Patch Electrode
NA · 3 location(s) · InnoCon Medical · NCT06754189PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB
NA · 5 location(s) · Axonics, Inc. · NCT06789406Aquarius Pilot Study to Evaluate the New Axonics Trial System
NA · 2 location(s) · Axonics, Inc. · NCT07335484NXT Post-Market Clinical Follow-up
Phase N/A · 5 location(s) · Laborie Medical Technologies Inc. · NCT06336304Study of 30-Minute Stimulation With the Neuspera Sacral Neuromodulation (SNM) System
NA · 1 location(s) · Neuspera Medical, Inc. · NCT07247136Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-Wet
NA · 1 location(s) · Children's Hospital of Chongqing Medical University · NCT06201013UCon Treatment of Overactive Bladder (OAB) in Males
NA · 1 location(s) · InnoCon Medical · NCT05874375Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
NA · 1 location(s) · Loma Linda University · NCT04527445Effect of Neuromodulation and Therapeutic Exercise in Urinary Incontinence
NA · 1 location(s) · Fundación Universidad Católica de Valencia San Vicente Márti · NCT06783374APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
NA · 10 location(s) · Medstar Health Research Institute · NCT06797245Augmenting Urinary Reflex Activity Study 4 (Including eXtended Indications)
NA · 7 location(s) · Amber Therapeutics Ltd · NCT06885931Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women
NA · 9 location(s) · InMode MD Ltd. · NCT07209397TReating Incontinence for Underlying Mental and Physical Health
Phase 4 · 2 location(s) · University of California, San Francisco · NCT05362292Low-intensity Shockwave Therapy Versus Solifenacin for the Treatment of Overactive Bladder in Women
Phase 4 · 1 location(s) · Mansoura University · NCT07473310Implementation of the App Tät®II for Treatment of Urgency and Mixed Urinary Incontinence
Phase N/A · 1 location(s) · Umeå University · NCT07038811Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD)
NA · 3 location(s) · InnoCon Medical · NCT06091566Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
Phase 4 · 2 location(s) · University of South Florida · NCT04305743A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
NA · 22 location(s) · Valencia Technologies Corporation · NCT05685433Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device
NA · 10 location(s) · MedtronicNeuro · NCT07456865Clinical Efficacy Evaluation of Electroacupuncture as Adjuvant Therapy for Female Patients With Overactive Bladder
NA · 1 location(s) · Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation · NCT05997992Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06161506Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrus
Phase N/A · 1 location(s) · Alexis Dieter · NCT07025044
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.